Global Negative Pressure Myofascial Therapy Device Market Growth 2026-2032
The global Negative Pressure Myofascial Therapy Device market size is predicted to grow from US$ 47.15 million in 2025 to US$ 86.91 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.
Negative Pressure Myofascial Therapy Device refers to a professional therapeutic device that applies controlled negative pressure to the skin and underlying soft tissue through suction cups, treatment heads or motorized tissue-mobilization handpieces. The device lifts, stretches, glides or rhythmically mobilizes fascia, connective tissue and adjacent muscular structures, supporting device-assisted manual therapy and rehabilitation. Commercial systems use continuous, pulsating, intermittent or programmed negative-pressure delivery, while selected platforms combine vacuum with mechanical vibration, motorized tissue mobilization or alternating pressure cycles. Representative professional devices provide adjustable treatment intensity and interchangeable treatment heads to adapt treatment depth, body area and tissue condition. The principal product forms are cup-based vacuum mobilization systems and more integrated motorized or pneumatic tissue-mobilization systems. Negative Pressure Myofascial Therapy Devices are mainly used for myofascial rehabilitation, scar and adhesion management, edema management and sports recovery, with treatment scenarios extending to plantar fascia disorders, muscular and tendinous injuries, postoperative fibrosis, burn scars and lymphatic congestion. Professional products increasingly incorporate precise pressure control, multiple operating modes, preset protocols and ergonomic treatment interfaces to improve treatment reproducibility and therapist efficiency.
Key Findings
Global sales reached approximately 6,650 units in 2025 and are estimated at approximately 7,190 units in 2026
Average selling price is estimated at approximately US$7,250 per unit in 2025 and US$7,360 per unit in 2026
Europe represents the densest manufacturing cluster, with most confirmed core suppliers headquartered across major European rehabilitation equipment markets
Demand is concentrated in myofascial rehabilitation, scar rehabilitation, edema management and sports recovery
Market Trends
The Negative Pressure Myofascial Therapy Device market is moving from relatively simple vacuum-assisted manual treatment toward more controlled, programmable and application-specific tissue mobilization. Current professional systems increasingly offer adjustable pressure, continuous and pulsating modes, interchangeable cups, roller heads, motorized handpieces and preset treatment programs, enabling therapists to adapt treatment intensity to tissue condition and anatomical area. LymphaTouch Pro, for example, provides controlled negative pressure up to 400 mmHg for fascia, soft tissue and swelling applications, while 6D Action supports both continuous and pulsating vacuum with multiple cup configurations. Other professional platforms use sequential suction, pneumatic pulsation or motorized microstimulation to create more reproducible tissue movement. The long-term product direction is therefore toward greater treatment precision, protocol standardization, ergonomic therapist operation and broader integration into rehabilitation workflows. Demand is also broadening from general soft-tissue mobilization toward more specialized treatment of fibrosis, adherent scars, edema and postoperative functional restrictions. EUREDUC, LPG and icoone product documentation demonstrates this shift toward targeted scar, fibrosis and connective-tissue rehabilitation rather than undifferentiated vacuum massage.
Market Dynamics
Drivers
Expansion of rehabilitation demand is the fundamental demand-side driver for Negative Pressure Myofascial Therapy Devices. The World Health Organization estimates that approximately 2.4 billion people worldwide live with health conditions that may benefit from rehabilitation, while World Physiotherapy reported more than 2.13 million physiotherapists globally in 2024. This large professional treatment base supports gradual adoption of device-assisted soft-tissue techniques as clinics seek to improve therapist ergonomics, treatment consistency and service capacity. At the clinical level, demand is reinforced by musculoskeletal disorders, postoperative recovery, scar management, lymphatic congestion and sports injuries. The ability of controlled negative pressure to complement manual therapy across several of these treatment pathways gives the category a broader utilization base than a single-indication rehabilitation device.
Restraints
Market expansion is restrained by the relatively specialized positioning of Negative Pressure Myofascial Therapy Devices and by the continued availability of lower-cost manual treatment techniques and alternative rehabilitation technologies. Professional systems require equipment investment, practitioner training, cleaning and maintenance of treatment heads, and in some markets medical-device compliance or structured clinical protocols. Treatment outcomes also depend on therapist technique, patient selection and appropriate pressure settings, making adoption less standardized than for some highly protocolized rehabilitation modalities. The category additionally competes for clinic capital expenditure with shockwave therapy, therapeutic ultrasound, electrotherapy, manual myofascial techniques and other soft-tissue mobilization tools. These factors limit rapid penetration among smaller clinics where equipment utilization rates may not justify purchasing multiple specialized systems.
Opportunities
The strongest expansion opportunities are emerging in applications where controlled tissue lifting and mobilization provide a clear functional complement to manual rehabilitation. Postoperative scar adhesion, fibrosis following orthopedic or breast procedures, burn-scar rehabilitation, secondary edema and lymphatic disorders offer particularly relevant clinical pathways because tissue stiffness and restricted mobility can persist beyond the acute treatment phase. LPG identifies scars, fibrosis, orthopedic postoperative care and lymphatic applications among its medical treatment areas, while icoone positions its medical technology for postoperative fibrosis and connective-tissue rehabilitation. Sports rehabilitation represents another scalable opportunity as portable systems increasingly enter professional athletic recovery, acute injury management and muscle-tension treatment. The combination of established physiotherapy markets and relatively low penetration of specialized negative-pressure devices also leaves room for distributor expansion in Asia, Latin America and other developing rehabilitation markets.
Challenges
A major structural challenge is the lack of completely standardized terminology across the industry. Similar mechanical principles may be marketed as negative-pressure therapy, vacuum massage, depressomassage, pneumatic pulsation, skin lifting or mechanostimulation, while medical, rehabilitation, wellness and aesthetic positioning may differ by product and jurisdiction. This makes product comparison, reimbursement assessment and customer education more difficult. Clinical evidence is also uneven across brands and indications, requiring manufacturers to strengthen application-specific validation rather than relying solely on general soft-tissue claims. Regulatory classifications and permitted therapeutic claims vary across countries, increasing commercialization complexity for smaller suppliers. At the same time, greater product differentiation will be required as professional customers increasingly compare pressure accuracy, operating modes, handpiece ergonomics, treatment protocols, clinical evidence, training support and after-sales service rather than vacuum generation alone.
Industry Chain Analysis
The upstream industry chain of Negative Pressure Myofascial Therapy Devices consists primarily of compact vacuum pumps, valves, pressure sensors, tubing, treatment cups, motorized or rolling treatment heads, control electronics, displays, power modules and structural components. Medical-grade plastics, transparent polymers, glass treatment cups and sterilizable contact components are used according to product architecture. The importance of individual upstream components varies substantially by product type: cup vacuum mobilization devices rely more heavily on pump precision, pressure regulation and interchangeable suction interfaces, while motorized vacuum mobilization systems add motors, mechanical transmission structures and more sophisticated treatment heads. Official technical documentation from EUREDUC and 6D Action illustrates the combination of pressure-control hardware, suction tubing and treatment heads that forms the functional core of professional vacuum therapy systems.
Midstream value creation centers on system design, negative-pressure control, treatment-head engineering, medical-device compliance, software and protocol development, assembly, quality control and practitioner training. Downstream customers include physiotherapy practices, rehabilitation departments, orthopedic rehabilitation services, scar and burn rehabilitation programs, lymphatic and edema treatment providers, and professional sports medicine teams. The principal value contribution shifts from component hardware toward clinical usability, treatment reproducibility, evidence support and service capability as products move toward premium professional systems. Consequently, manufacturers with well-developed training networks, application protocols and distributor service systems can maintain stronger pricing than suppliers competing primarily on pump hardware or basic suction functionality.
Segment Insights
By product type, Cup Vacuum Mobilization represents the broadest architecture across the confirmed product portfolio because it combines relatively simple equipment design with flexible treatment-head selection and direct therapist control. Motorized Vacuum Mobilization occupies a more integrated and generally higher-value position, combining suction with powered rollers, microstimulators or mechanical tissue-mobilization mechanisms. Pneumatic Pulsation Therapy and Bidirectional Pressure Cycling remain more specialized technology routes, differentiated by the way pressure is generated and alternated rather than by conventional continuous suction. Across vacuum-control configurations, Multimode Vacuum has become an important product direction because continuous and pulsating operation allows one platform to address different tissue conditions and treatment techniques. Professional products now span Low Vacuum Class, Medium Vacuum Class and High Vacuum Class specifications, while products without directly comparable disclosed pressure parameters remain within Other.
From the application perspective, Myofascial Rehabilitation forms the fundamental clinical use base, while Scar Rehabilitation and Edema Management provide more specialized treatment demand in postoperative and chronic-care pathways. Sports Recovery broadens the addressable customer base through acute injury management, muscle recovery and high-performance rehabilitation. These application groups are differentiated by the primary treatment objective rather than treatment location: postoperative cases aimed at reducing edema are classified under Edema Management, while cases aimed at mobilizing adherent scar tissue are classified under Scar Rehabilitation. This approach maintains clearer segment boundaries and better reflects how professional devices are selected and used in practice.
Downstream Market Opportunities
Downstream opportunities are increasingly concentrated in clearly defined treatment scenarios rather than generic massage use. In musculoskeletal rehabilitation, target cases include plantar fascia disorders, tennis elbow, frozen shoulder, tendon injuries, muscle tightness and other restrictions requiring soft-tissue mobilization. In postoperative care, negative-pressure tissue mobilization is used for adherent scars, fibrosis and mobility restrictions following orthopedic and breast procedures, while burn rehabilitation creates demand for controlled treatment of fibrotic and retractile scar tissue. Lymphatic and edema applications include postoperative swelling and secondary lymphatic congestion, while sports applications extend from acute injury recovery to pre-competition preparation and post-exercise muscle recovery. These applications are already reflected in professional product protocols and clinical use cases from major suppliers, providing a practical basis for further adoption by physiotherapists and rehabilitation specialists.
Regional Insights
Europe is the most concentrated supply-side region for Negative Pressure Myofascial Therapy Devices, with the majority of confirmed core manufacturers headquartered in France, Finland, Germany, Italy and Spain. The region combines an established physiotherapy profession, specialized medical-device manufacturing capabilities and long-standing use of vacuum-based tissue mobilization. Several European suppliers manufacture professional medical devices locally and emphasize controlled pressure, scar rehabilitation, connective-tissue treatment and medical compliance. EUREDUC, for example, states that its professional vacuotherapy medical devices are designed and manufactured in France under ISO 13485, while German manufacturer pneumed continues to develop pneumatic pulsation systems for rehabilitation and connective-tissue applications.
Japan represents a distinctive Asian market with an established domestic fascia-focused product route led by Medicell, while other Asian markets remain more fragmented and rely more heavily on imported professional systems or adjacent local vacuum-therapy products. MJ COMPANY continues to position Medicell around fascia release, treatment, sports and other professional applications. Brazil provides the most visible Latin American manufacturing presence within the confirmed supplier set, while North America is important primarily as a professional adoption and commercialization market for European and other international systems. Regional growth will therefore depend not only on rehabilitation demand but also on practitioner education, distributor coverage, medical-device registration and the availability of localized clinical protocols.
Competitive Landscape Analysis
The Negative Pressure Myofascial Therapy Device market remains fragmented, with 11 confirmed core competitive suppliers spanning several distinct technology architectures rather than a single standardized product platform. Competition is therefore driven less by scale alone and more by treatment mechanism, clinical positioning, pressure-control capability, installed professional network and practitioner support. European suppliers form the dominant manufacturing cluster and range from relatively focused vacuum and pneumatic systems to higher-end motorized tissue-mobilization platforms. LPG SYSTEMS emphasizes multi-head mechanical tissue stimulation for scars, fibrosis, circulatory disorders and muscular conditions, while LymphaTouch focuses on controlled negative pressure for fascia, soft tissue, edema and scar therapy. pneumed differentiates through intermittent pneumatic pulsation, EUREDUC through medical depressomassage systems, and I-Tech Industries through motorized microstimulation for connective-tissue treatment. Japan’s MJ COMPANY adds a distinct fascia-focused domestic platform, while other suppliers compete through portability, multimode vacuum, specialized treatment heads and regional distribution. No single competitive metric adequately describes the market; sustainable positioning increasingly depends on combining clinical evidence, practitioner training, product ergonomics, regulatory compliance and after-sales support.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Negative Pressure Myofascial Therapy Device Industry Forecast” looks at past sales and reviews total world Negative Pressure Myofascial Therapy Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Negative Pressure Myofascial Therapy Device sales for 2026 through 2032. With Negative Pressure Myofascial Therapy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Negative Pressure Myofascial Therapy Device industry.
This Insight Report provides a comprehensive analysis of the global Negative Pressure Myofascial Therapy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Negative Pressure Myofascial Therapy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Negative Pressure Myofascial Therapy Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Negative Pressure Myofascial Therapy Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Negative Pressure Myofascial Therapy Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Negative Pressure Myofascial Therapy Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Negative Pressure Myofascial Therapy Device refers to a professional therapeutic device that applies controlled negative pressure to the skin and underlying soft tissue through suction cups, treatment heads or motorized tissue-mobilization handpieces. The device lifts, stretches, glides or rhythmically mobilizes fascia, connective tissue and adjacent muscular structures, supporting device-assisted manual therapy and rehabilitation. Commercial systems use continuous, pulsating, intermittent or programmed negative-pressure delivery, while selected platforms combine vacuum with mechanical vibration, motorized tissue mobilization or alternating pressure cycles. Representative professional devices provide adjustable treatment intensity and interchangeable treatment heads to adapt treatment depth, body area and tissue condition. The principal product forms are cup-based vacuum mobilization systems and more integrated motorized or pneumatic tissue-mobilization systems. Negative Pressure Myofascial Therapy Devices are mainly used for myofascial rehabilitation, scar and adhesion management, edema management and sports recovery, with treatment scenarios extending to plantar fascia disorders, muscular and tendinous injuries, postoperative fibrosis, burn scars and lymphatic congestion. Professional products increasingly incorporate precise pressure control, multiple operating modes, preset protocols and ergonomic treatment interfaces to improve treatment reproducibility and therapist efficiency.
Key Findings
Global sales reached approximately 6,650 units in 2025 and are estimated at approximately 7,190 units in 2026
Average selling price is estimated at approximately US$7,250 per unit in 2025 and US$7,360 per unit in 2026
Europe represents the densest manufacturing cluster, with most confirmed core suppliers headquartered across major European rehabilitation equipment markets
Demand is concentrated in myofascial rehabilitation, scar rehabilitation, edema management and sports recovery
Market Trends
The Negative Pressure Myofascial Therapy Device market is moving from relatively simple vacuum-assisted manual treatment toward more controlled, programmable and application-specific tissue mobilization. Current professional systems increasingly offer adjustable pressure, continuous and pulsating modes, interchangeable cups, roller heads, motorized handpieces and preset treatment programs, enabling therapists to adapt treatment intensity to tissue condition and anatomical area. LymphaTouch Pro, for example, provides controlled negative pressure up to 400 mmHg for fascia, soft tissue and swelling applications, while 6D Action supports both continuous and pulsating vacuum with multiple cup configurations. Other professional platforms use sequential suction, pneumatic pulsation or motorized microstimulation to create more reproducible tissue movement. The long-term product direction is therefore toward greater treatment precision, protocol standardization, ergonomic therapist operation and broader integration into rehabilitation workflows. Demand is also broadening from general soft-tissue mobilization toward more specialized treatment of fibrosis, adherent scars, edema and postoperative functional restrictions. EUREDUC, LPG and icoone product documentation demonstrates this shift toward targeted scar, fibrosis and connective-tissue rehabilitation rather than undifferentiated vacuum massage.
Market Dynamics
Drivers
Expansion of rehabilitation demand is the fundamental demand-side driver for Negative Pressure Myofascial Therapy Devices. The World Health Organization estimates that approximately 2.4 billion people worldwide live with health conditions that may benefit from rehabilitation, while World Physiotherapy reported more than 2.13 million physiotherapists globally in 2024. This large professional treatment base supports gradual adoption of device-assisted soft-tissue techniques as clinics seek to improve therapist ergonomics, treatment consistency and service capacity. At the clinical level, demand is reinforced by musculoskeletal disorders, postoperative recovery, scar management, lymphatic congestion and sports injuries. The ability of controlled negative pressure to complement manual therapy across several of these treatment pathways gives the category a broader utilization base than a single-indication rehabilitation device.
Restraints
Market expansion is restrained by the relatively specialized positioning of Negative Pressure Myofascial Therapy Devices and by the continued availability of lower-cost manual treatment techniques and alternative rehabilitation technologies. Professional systems require equipment investment, practitioner training, cleaning and maintenance of treatment heads, and in some markets medical-device compliance or structured clinical protocols. Treatment outcomes also depend on therapist technique, patient selection and appropriate pressure settings, making adoption less standardized than for some highly protocolized rehabilitation modalities. The category additionally competes for clinic capital expenditure with shockwave therapy, therapeutic ultrasound, electrotherapy, manual myofascial techniques and other soft-tissue mobilization tools. These factors limit rapid penetration among smaller clinics where equipment utilization rates may not justify purchasing multiple specialized systems.
Opportunities
The strongest expansion opportunities are emerging in applications where controlled tissue lifting and mobilization provide a clear functional complement to manual rehabilitation. Postoperative scar adhesion, fibrosis following orthopedic or breast procedures, burn-scar rehabilitation, secondary edema and lymphatic disorders offer particularly relevant clinical pathways because tissue stiffness and restricted mobility can persist beyond the acute treatment phase. LPG identifies scars, fibrosis, orthopedic postoperative care and lymphatic applications among its medical treatment areas, while icoone positions its medical technology for postoperative fibrosis and connective-tissue rehabilitation. Sports rehabilitation represents another scalable opportunity as portable systems increasingly enter professional athletic recovery, acute injury management and muscle-tension treatment. The combination of established physiotherapy markets and relatively low penetration of specialized negative-pressure devices also leaves room for distributor expansion in Asia, Latin America and other developing rehabilitation markets.
Challenges
A major structural challenge is the lack of completely standardized terminology across the industry. Similar mechanical principles may be marketed as negative-pressure therapy, vacuum massage, depressomassage, pneumatic pulsation, skin lifting or mechanostimulation, while medical, rehabilitation, wellness and aesthetic positioning may differ by product and jurisdiction. This makes product comparison, reimbursement assessment and customer education more difficult. Clinical evidence is also uneven across brands and indications, requiring manufacturers to strengthen application-specific validation rather than relying solely on general soft-tissue claims. Regulatory classifications and permitted therapeutic claims vary across countries, increasing commercialization complexity for smaller suppliers. At the same time, greater product differentiation will be required as professional customers increasingly compare pressure accuracy, operating modes, handpiece ergonomics, treatment protocols, clinical evidence, training support and after-sales service rather than vacuum generation alone.
Industry Chain Analysis
The upstream industry chain of Negative Pressure Myofascial Therapy Devices consists primarily of compact vacuum pumps, valves, pressure sensors, tubing, treatment cups, motorized or rolling treatment heads, control electronics, displays, power modules and structural components. Medical-grade plastics, transparent polymers, glass treatment cups and sterilizable contact components are used according to product architecture. The importance of individual upstream components varies substantially by product type: cup vacuum mobilization devices rely more heavily on pump precision, pressure regulation and interchangeable suction interfaces, while motorized vacuum mobilization systems add motors, mechanical transmission structures and more sophisticated treatment heads. Official technical documentation from EUREDUC and 6D Action illustrates the combination of pressure-control hardware, suction tubing and treatment heads that forms the functional core of professional vacuum therapy systems.
Midstream value creation centers on system design, negative-pressure control, treatment-head engineering, medical-device compliance, software and protocol development, assembly, quality control and practitioner training. Downstream customers include physiotherapy practices, rehabilitation departments, orthopedic rehabilitation services, scar and burn rehabilitation programs, lymphatic and edema treatment providers, and professional sports medicine teams. The principal value contribution shifts from component hardware toward clinical usability, treatment reproducibility, evidence support and service capability as products move toward premium professional systems. Consequently, manufacturers with well-developed training networks, application protocols and distributor service systems can maintain stronger pricing than suppliers competing primarily on pump hardware or basic suction functionality.
Segment Insights
By product type, Cup Vacuum Mobilization represents the broadest architecture across the confirmed product portfolio because it combines relatively simple equipment design with flexible treatment-head selection and direct therapist control. Motorized Vacuum Mobilization occupies a more integrated and generally higher-value position, combining suction with powered rollers, microstimulators or mechanical tissue-mobilization mechanisms. Pneumatic Pulsation Therapy and Bidirectional Pressure Cycling remain more specialized technology routes, differentiated by the way pressure is generated and alternated rather than by conventional continuous suction. Across vacuum-control configurations, Multimode Vacuum has become an important product direction because continuous and pulsating operation allows one platform to address different tissue conditions and treatment techniques. Professional products now span Low Vacuum Class, Medium Vacuum Class and High Vacuum Class specifications, while products without directly comparable disclosed pressure parameters remain within Other.
From the application perspective, Myofascial Rehabilitation forms the fundamental clinical use base, while Scar Rehabilitation and Edema Management provide more specialized treatment demand in postoperative and chronic-care pathways. Sports Recovery broadens the addressable customer base through acute injury management, muscle recovery and high-performance rehabilitation. These application groups are differentiated by the primary treatment objective rather than treatment location: postoperative cases aimed at reducing edema are classified under Edema Management, while cases aimed at mobilizing adherent scar tissue are classified under Scar Rehabilitation. This approach maintains clearer segment boundaries and better reflects how professional devices are selected and used in practice.
Downstream Market Opportunities
Downstream opportunities are increasingly concentrated in clearly defined treatment scenarios rather than generic massage use. In musculoskeletal rehabilitation, target cases include plantar fascia disorders, tennis elbow, frozen shoulder, tendon injuries, muscle tightness and other restrictions requiring soft-tissue mobilization. In postoperative care, negative-pressure tissue mobilization is used for adherent scars, fibrosis and mobility restrictions following orthopedic and breast procedures, while burn rehabilitation creates demand for controlled treatment of fibrotic and retractile scar tissue. Lymphatic and edema applications include postoperative swelling and secondary lymphatic congestion, while sports applications extend from acute injury recovery to pre-competition preparation and post-exercise muscle recovery. These applications are already reflected in professional product protocols and clinical use cases from major suppliers, providing a practical basis for further adoption by physiotherapists and rehabilitation specialists.
Regional Insights
Europe is the most concentrated supply-side region for Negative Pressure Myofascial Therapy Devices, with the majority of confirmed core manufacturers headquartered in France, Finland, Germany, Italy and Spain. The region combines an established physiotherapy profession, specialized medical-device manufacturing capabilities and long-standing use of vacuum-based tissue mobilization. Several European suppliers manufacture professional medical devices locally and emphasize controlled pressure, scar rehabilitation, connective-tissue treatment and medical compliance. EUREDUC, for example, states that its professional vacuotherapy medical devices are designed and manufactured in France under ISO 13485, while German manufacturer pneumed continues to develop pneumatic pulsation systems for rehabilitation and connective-tissue applications.
Japan represents a distinctive Asian market with an established domestic fascia-focused product route led by Medicell, while other Asian markets remain more fragmented and rely more heavily on imported professional systems or adjacent local vacuum-therapy products. MJ COMPANY continues to position Medicell around fascia release, treatment, sports and other professional applications. Brazil provides the most visible Latin American manufacturing presence within the confirmed supplier set, while North America is important primarily as a professional adoption and commercialization market for European and other international systems. Regional growth will therefore depend not only on rehabilitation demand but also on practitioner education, distributor coverage, medical-device registration and the availability of localized clinical protocols.
Competitive Landscape Analysis
The Negative Pressure Myofascial Therapy Device market remains fragmented, with 11 confirmed core competitive suppliers spanning several distinct technology architectures rather than a single standardized product platform. Competition is therefore driven less by scale alone and more by treatment mechanism, clinical positioning, pressure-control capability, installed professional network and practitioner support. European suppliers form the dominant manufacturing cluster and range from relatively focused vacuum and pneumatic systems to higher-end motorized tissue-mobilization platforms. LPG SYSTEMS emphasizes multi-head mechanical tissue stimulation for scars, fibrosis, circulatory disorders and muscular conditions, while LymphaTouch focuses on controlled negative pressure for fascia, soft tissue, edema and scar therapy. pneumed differentiates through intermittent pneumatic pulsation, EUREDUC through medical depressomassage systems, and I-Tech Industries through motorized microstimulation for connective-tissue treatment. Japan’s MJ COMPANY adds a distinct fascia-focused domestic platform, while other suppliers compete through portability, multimode vacuum, specialized treatment heads and regional distribution. No single competitive metric adequately describes the market; sustainable positioning increasingly depends on combining clinical evidence, practitioner training, product ergonomics, regulatory compliance and after-sales support.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Negative Pressure Myofascial Therapy Device Industry Forecast” looks at past sales and reviews total world Negative Pressure Myofascial Therapy Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Negative Pressure Myofascial Therapy Device sales for 2026 through 2032. With Negative Pressure Myofascial Therapy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Negative Pressure Myofascial Therapy Device industry.
This Insight Report provides a comprehensive analysis of the global Negative Pressure Myofascial Therapy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Negative Pressure Myofascial Therapy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Negative Pressure Myofascial Therapy Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Negative Pressure Myofascial Therapy Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Negative Pressure Myofascial Therapy Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Negative Pressure Myofascial Therapy Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Cup Vacuum Mobilization
- Motorized Vacuum Mobilization
- Pneumatic Pulsation Therapy
- Bidirectional Pressure Cycling
- Other
Segmentation by Vacuum Mode:
- Continuous Vacuum
- Pulsed Vacuum
- Intermittent Vacuum
- Bidirectional Pressure
- Other
Segmentation by Application:
- Myofascial Rehabilitation
- Scar Rehabilitation
- Edema Management
- Sports Recovery
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- LPG SYSTEMS
- LymphaTouch Oy
- pneumed GmbH
- ?lectronique du Mazet
- EUREDUC
- SKINEXIANS SAS
- I-Tech Industries s.r.l.
- IBRAMED
- Biotronic Advance Develops
- 6D Tape Inc.
- MJ COMPANY
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Negative Pressure Myofascial Therapy Device market?
- What factors are driving Negative Pressure Myofascial Therapy Device market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Negative Pressure Myofascial Therapy Device market opportunities vary by end market size?
- How does Negative Pressure Myofascial Therapy Device break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Negative Pressure Myofascial Therapy Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Negative Pressure Myofascial Therapy Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Negative Pressure Myofascial Therapy Device by Country/Region, 2021, 2025 & 2032
2.2 Negative Pressure Myofascial Therapy Device Segment by Type
2.2.1 Cup Vacuum Mobilization
2.2.2 Motorized Vacuum Mobilization
2.2.3 Pneumatic Pulsation Therapy
2.2.4 Bidirectional Pressure Cycling
2.2.5 Other
2.2.6 Negative Pressure Myofascial Therapy Device Sales by Type
2.2.6.1 Global Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
2.2.6.2 Global Negative Pressure Myofascial Therapy Device Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Negative Pressure Myofascial Therapy Device Sale Price by Type (2021-2026)
2.3 Negative Pressure Myofascial Therapy Device Segment by Vacuum Mode
2.3.1 Continuous Vacuum
2.3.2 Pulsed Vacuum
2.3.3 Intermittent Vacuum
2.3.4 Bidirectional Pressure
2.3.5 Other
2.3.6 Negative Pressure Myofascial Therapy Device Sales by Vacuum Mode
2.3.6.1 Global Negative Pressure Myofascial Therapy Device Sales Market Share by Vacuum Mode (2021-2026)
2.3.6.2 Global Negative Pressure Myofascial Therapy Device Revenue and Market Share by Vacuum Mode (2021-2026)
2.3.6.3 Global Negative Pressure Myofascial Therapy Device Sale Price by Vacuum Mode (2021-2026)
2.4 Negative Pressure Myofascial Therapy Device Segment by Application
2.4.1 Myofascial Rehabilitation
2.4.2 Scar Rehabilitation
2.4.3 Edema Management
2.4.4 Sports Recovery
2.4.5 Other
2.4.6 Negative Pressure Myofascial Therapy Device Sales by Application
2.4.6.1 Global Negative Pressure Myofascial Therapy Device Sale Market Share by Application (2021-2026)
2.4.6.2 Global Negative Pressure Myofascial Therapy Device Revenue and Market Share by Application (2021-2026)
2.4.6.3 Global Negative Pressure Myofascial Therapy Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Negative Pressure Myofascial Therapy Device Breakdown Data by Company
3.1.1 Global Negative Pressure Myofascial Therapy Device Annual Sales by Company (2021-2026)
3.1.2 Global Negative Pressure Myofascial Therapy Device Sales Market Share by Company (2021-2026)
3.2 Global Negative Pressure Myofascial Therapy Device Annual Revenue by Company (2021-2026)
3.2.1 Global Negative Pressure Myofascial Therapy Device Revenue by Company (2021-2026)
3.2.2 Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Company (2021-2026)
3.3 Global Negative Pressure Myofascial Therapy Device Sale Price by Company
3.4 Key Manufacturers Negative Pressure Myofascial Therapy Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Negative Pressure Myofascial Therapy Device Product Location Distribution
3.4.2 Players Negative Pressure Myofascial Therapy Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEGATIVE PRESSURE MYOFASCIAL THERAPY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Negative Pressure Myofascial Therapy Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Negative Pressure Myofascial Therapy Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Negative Pressure Myofascial Therapy Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Negative Pressure Myofascial Therapy Device Market Size by Country/Region (2021-2026)
4.2.1 Global Negative Pressure Myofascial Therapy Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Negative Pressure Myofascial Therapy Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Negative Pressure Myofascial Therapy Device Sales Growth
4.4 APAC Negative Pressure Myofascial Therapy Device Sales Growth
4.5 Europe Negative Pressure Myofascial Therapy Device Sales Growth
4.6 Middle East & Africa Negative Pressure Myofascial Therapy Device Sales Growth
5 AMERICAS
5.1 Americas Negative Pressure Myofascial Therapy Device Sales by Country
5.1.1 Americas Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026)
5.1.2 Americas Negative Pressure Myofascial Therapy Device Revenue by Country (2021-2026)
5.2 Americas Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026)
5.3 Americas Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Negative Pressure Myofascial Therapy Device Sales by Region
6.1.1 APAC Negative Pressure Myofascial Therapy Device Sales by Region (2021-2026)
6.1.2 APAC Negative Pressure Myofascial Therapy Device Revenue by Region (2021-2026)
6.2 APAC Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026)
6.3 APAC Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Negative Pressure Myofascial Therapy Device by Country
7.1.1 Europe Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026)
7.1.2 Europe Negative Pressure Myofascial Therapy Device Revenue by Country (2021-2026)
7.2 Europe Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026)
7.3 Europe Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Negative Pressure Myofascial Therapy Device by Country
8.1.1 Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Negative Pressure Myofascial Therapy Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026)
8.3 Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Negative Pressure Myofascial Therapy Device
10.3 Manufacturing Process Analysis of Negative Pressure Myofascial Therapy Device
10.4 Industry Chain Structure of Negative Pressure Myofascial Therapy Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Negative Pressure Myofascial Therapy Device Distributors
11.3 Negative Pressure Myofascial Therapy Device Customer
12 WORLD FORECAST REVIEW FOR NEGATIVE PRESSURE MYOFASCIAL THERAPY DEVICE BY GEOGRAPHIC REGION
12.1 Global Negative Pressure Myofascial Therapy Device Market Size Forecast by Region
12.1.1 Global Negative Pressure Myofascial Therapy Device Forecast by Region (2027-2032)
12.1.2 Global Negative Pressure Myofascial Therapy Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Negative Pressure Myofascial Therapy Device Forecast by Type (2027-2032)
12.7 Global Negative Pressure Myofascial Therapy Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 LPG SYSTEMS
13.1.1 LPG SYSTEMS Company Information
13.1.2 LPG SYSTEMS Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.1.3 LPG SYSTEMS Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 LPG SYSTEMS Main Business Overview
13.1.5 LPG SYSTEMS Latest Developments
13.2 LymphaTouch Oy
13.2.1 LymphaTouch Oy Company Information
13.2.2 LymphaTouch Oy Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.2.3 LymphaTouch Oy Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 LymphaTouch Oy Main Business Overview
13.2.5 LymphaTouch Oy Latest Developments
13.3 pneumed GmbH
13.3.1 pneumed GmbH Company Information
13.3.2 pneumed GmbH Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.3.3 pneumed GmbH Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 pneumed GmbH Main Business Overview
13.3.5 pneumed GmbH Latest Developments
13.4 ?lectronique du Mazet
13.4.1 ?lectronique du Mazet Company Information
13.4.2 ?lectronique du Mazet Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.4.3 ?lectronique du Mazet Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 ?lectronique du Mazet Main Business Overview
13.4.5 ?lectronique du Mazet Latest Developments
13.5 EUREDUC
13.5.1 EUREDUC Company Information
13.5.2 EUREDUC Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.5.3 EUREDUC Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 EUREDUC Main Business Overview
13.5.5 EUREDUC Latest Developments
13.6 SKINEXIANS SAS
13.6.1 SKINEXIANS SAS Company Information
13.6.2 SKINEXIANS SAS Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.6.3 SKINEXIANS SAS Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 SKINEXIANS SAS Main Business Overview
13.6.5 SKINEXIANS SAS Latest Developments
13.7 I-Tech Industries s.r.l.
13.7.1 I-Tech Industries s.r.l. Company Information
13.7.2 I-Tech Industries s.r.l. Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.7.3 I-Tech Industries s.r.l. Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 I-Tech Industries s.r.l. Main Business Overview
13.7.5 I-Tech Industries s.r.l. Latest Developments
13.8 IBRAMED
13.8.1 IBRAMED Company Information
13.8.2 IBRAMED Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.8.3 IBRAMED Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 IBRAMED Main Business Overview
13.8.5 IBRAMED Latest Developments
13.9 Biotronic Advance Develops
13.9.1 Biotronic Advance Develops Company Information
13.9.2 Biotronic Advance Develops Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.9.3 Biotronic Advance Develops Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Biotronic Advance Develops Main Business Overview
13.9.5 Biotronic Advance Develops Latest Developments
13.10 6D Tape Inc.
13.10.1 6D Tape Inc. Company Information
13.10.2 6D Tape Inc. Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.10.3 6D Tape Inc. Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 6D Tape Inc. Main Business Overview
13.10.5 6D Tape Inc. Latest Developments
13.11 MJ COMPANY
13.11.1 MJ COMPANY Company Information
13.11.2 MJ COMPANY Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.11.3 MJ COMPANY Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MJ COMPANY Main Business Overview
13.11.5 MJ COMPANY Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Negative Pressure Myofascial Therapy Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Negative Pressure Myofascial Therapy Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Negative Pressure Myofascial Therapy Device by Country/Region, 2021, 2025 & 2032
2.2 Negative Pressure Myofascial Therapy Device Segment by Type
2.2.1 Cup Vacuum Mobilization
2.2.2 Motorized Vacuum Mobilization
2.2.3 Pneumatic Pulsation Therapy
2.2.4 Bidirectional Pressure Cycling
2.2.5 Other
2.2.6 Negative Pressure Myofascial Therapy Device Sales by Type
2.2.6.1 Global Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
2.2.6.2 Global Negative Pressure Myofascial Therapy Device Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Negative Pressure Myofascial Therapy Device Sale Price by Type (2021-2026)
2.3 Negative Pressure Myofascial Therapy Device Segment by Vacuum Mode
2.3.1 Continuous Vacuum
2.3.2 Pulsed Vacuum
2.3.3 Intermittent Vacuum
2.3.4 Bidirectional Pressure
2.3.5 Other
2.3.6 Negative Pressure Myofascial Therapy Device Sales by Vacuum Mode
2.3.6.1 Global Negative Pressure Myofascial Therapy Device Sales Market Share by Vacuum Mode (2021-2026)
2.3.6.2 Global Negative Pressure Myofascial Therapy Device Revenue and Market Share by Vacuum Mode (2021-2026)
2.3.6.3 Global Negative Pressure Myofascial Therapy Device Sale Price by Vacuum Mode (2021-2026)
2.4 Negative Pressure Myofascial Therapy Device Segment by Application
2.4.1 Myofascial Rehabilitation
2.4.2 Scar Rehabilitation
2.4.3 Edema Management
2.4.4 Sports Recovery
2.4.5 Other
2.4.6 Negative Pressure Myofascial Therapy Device Sales by Application
2.4.6.1 Global Negative Pressure Myofascial Therapy Device Sale Market Share by Application (2021-2026)
2.4.6.2 Global Negative Pressure Myofascial Therapy Device Revenue and Market Share by Application (2021-2026)
2.4.6.3 Global Negative Pressure Myofascial Therapy Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Negative Pressure Myofascial Therapy Device Breakdown Data by Company
3.1.1 Global Negative Pressure Myofascial Therapy Device Annual Sales by Company (2021-2026)
3.1.2 Global Negative Pressure Myofascial Therapy Device Sales Market Share by Company (2021-2026)
3.2 Global Negative Pressure Myofascial Therapy Device Annual Revenue by Company (2021-2026)
3.2.1 Global Negative Pressure Myofascial Therapy Device Revenue by Company (2021-2026)
3.2.2 Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Company (2021-2026)
3.3 Global Negative Pressure Myofascial Therapy Device Sale Price by Company
3.4 Key Manufacturers Negative Pressure Myofascial Therapy Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Negative Pressure Myofascial Therapy Device Product Location Distribution
3.4.2 Players Negative Pressure Myofascial Therapy Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEGATIVE PRESSURE MYOFASCIAL THERAPY DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Negative Pressure Myofascial Therapy Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Negative Pressure Myofascial Therapy Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Negative Pressure Myofascial Therapy Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Negative Pressure Myofascial Therapy Device Market Size by Country/Region (2021-2026)
4.2.1 Global Negative Pressure Myofascial Therapy Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Negative Pressure Myofascial Therapy Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Negative Pressure Myofascial Therapy Device Sales Growth
4.4 APAC Negative Pressure Myofascial Therapy Device Sales Growth
4.5 Europe Negative Pressure Myofascial Therapy Device Sales Growth
4.6 Middle East & Africa Negative Pressure Myofascial Therapy Device Sales Growth
5 AMERICAS
5.1 Americas Negative Pressure Myofascial Therapy Device Sales by Country
5.1.1 Americas Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026)
5.1.2 Americas Negative Pressure Myofascial Therapy Device Revenue by Country (2021-2026)
5.2 Americas Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026)
5.3 Americas Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Negative Pressure Myofascial Therapy Device Sales by Region
6.1.1 APAC Negative Pressure Myofascial Therapy Device Sales by Region (2021-2026)
6.1.2 APAC Negative Pressure Myofascial Therapy Device Revenue by Region (2021-2026)
6.2 APAC Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026)
6.3 APAC Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Negative Pressure Myofascial Therapy Device by Country
7.1.1 Europe Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026)
7.1.2 Europe Negative Pressure Myofascial Therapy Device Revenue by Country (2021-2026)
7.2 Europe Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026)
7.3 Europe Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Negative Pressure Myofascial Therapy Device by Country
8.1.1 Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Negative Pressure Myofascial Therapy Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026)
8.3 Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Negative Pressure Myofascial Therapy Device
10.3 Manufacturing Process Analysis of Negative Pressure Myofascial Therapy Device
10.4 Industry Chain Structure of Negative Pressure Myofascial Therapy Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Negative Pressure Myofascial Therapy Device Distributors
11.3 Negative Pressure Myofascial Therapy Device Customer
12 WORLD FORECAST REVIEW FOR NEGATIVE PRESSURE MYOFASCIAL THERAPY DEVICE BY GEOGRAPHIC REGION
12.1 Global Negative Pressure Myofascial Therapy Device Market Size Forecast by Region
12.1.1 Global Negative Pressure Myofascial Therapy Device Forecast by Region (2027-2032)
12.1.2 Global Negative Pressure Myofascial Therapy Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Negative Pressure Myofascial Therapy Device Forecast by Type (2027-2032)
12.7 Global Negative Pressure Myofascial Therapy Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 LPG SYSTEMS
13.1.1 LPG SYSTEMS Company Information
13.1.2 LPG SYSTEMS Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.1.3 LPG SYSTEMS Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 LPG SYSTEMS Main Business Overview
13.1.5 LPG SYSTEMS Latest Developments
13.2 LymphaTouch Oy
13.2.1 LymphaTouch Oy Company Information
13.2.2 LymphaTouch Oy Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.2.3 LymphaTouch Oy Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 LymphaTouch Oy Main Business Overview
13.2.5 LymphaTouch Oy Latest Developments
13.3 pneumed GmbH
13.3.1 pneumed GmbH Company Information
13.3.2 pneumed GmbH Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.3.3 pneumed GmbH Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 pneumed GmbH Main Business Overview
13.3.5 pneumed GmbH Latest Developments
13.4 ?lectronique du Mazet
13.4.1 ?lectronique du Mazet Company Information
13.4.2 ?lectronique du Mazet Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.4.3 ?lectronique du Mazet Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 ?lectronique du Mazet Main Business Overview
13.4.5 ?lectronique du Mazet Latest Developments
13.5 EUREDUC
13.5.1 EUREDUC Company Information
13.5.2 EUREDUC Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.5.3 EUREDUC Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 EUREDUC Main Business Overview
13.5.5 EUREDUC Latest Developments
13.6 SKINEXIANS SAS
13.6.1 SKINEXIANS SAS Company Information
13.6.2 SKINEXIANS SAS Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.6.3 SKINEXIANS SAS Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 SKINEXIANS SAS Main Business Overview
13.6.5 SKINEXIANS SAS Latest Developments
13.7 I-Tech Industries s.r.l.
13.7.1 I-Tech Industries s.r.l. Company Information
13.7.2 I-Tech Industries s.r.l. Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.7.3 I-Tech Industries s.r.l. Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 I-Tech Industries s.r.l. Main Business Overview
13.7.5 I-Tech Industries s.r.l. Latest Developments
13.8 IBRAMED
13.8.1 IBRAMED Company Information
13.8.2 IBRAMED Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.8.3 IBRAMED Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 IBRAMED Main Business Overview
13.8.5 IBRAMED Latest Developments
13.9 Biotronic Advance Develops
13.9.1 Biotronic Advance Develops Company Information
13.9.2 Biotronic Advance Develops Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.9.3 Biotronic Advance Develops Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Biotronic Advance Develops Main Business Overview
13.9.5 Biotronic Advance Develops Latest Developments
13.10 6D Tape Inc.
13.10.1 6D Tape Inc. Company Information
13.10.2 6D Tape Inc. Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.10.3 6D Tape Inc. Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 6D Tape Inc. Main Business Overview
13.10.5 6D Tape Inc. Latest Developments
13.11 MJ COMPANY
13.11.1 MJ COMPANY Company Information
13.11.2 MJ COMPANY Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
13.11.3 MJ COMPANY Negative Pressure Myofascial Therapy Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 MJ COMPANY Main Business Overview
13.11.5 MJ COMPANY Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Negative Pressure Myofascial Therapy Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Negative Pressure Myofascial Therapy Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cup Vacuum Mobilization
Table 4. Major Players of Motorized Vacuum Mobilization
Table 5. Major Players of Pneumatic Pulsation Therapy
Table 6. Major Players of Bidirectional Pressure Cycling
Table 7. Major Players of Other
Table 8. Global Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026) & (Units)
Table 9. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
Table 10. Global Negative Pressure Myofascial Therapy Device Revenue by Type (2021-2026) & ($ million)
Table 11. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Type (2021-2026)
Table 12. Global Negative Pressure Myofascial Therapy Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Major Players of Continuous Vacuum
Table 14. Major Players of Pulsed Vacuum
Table 15. Major Players of Intermittent Vacuum
Table 16. Major Players of Bidirectional Pressure
Table 17. Major Players of Other
Table 18. Global Negative Pressure Myofascial Therapy Device Sales by Vacuum Mode (2021-2026) & (Units)
Table 19. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Vacuum Mode (2021-2026)
Table 20. Global Negative Pressure Myofascial Therapy Device Revenue by Vacuum Mode (2021-2026) & ($ million)
Table 21. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Vacuum Mode (2021-2026)
Table 22. Global Negative Pressure Myofascial Therapy Device Sale Price by Vacuum Mode (2021-2026) & (US$/Unit)
Table 23. Global Negative Pressure Myofascial Therapy Device Sale by Application (2021-2026) & (Units)
Table 24. Global Negative Pressure Myofascial Therapy Device Sale Market Share by Application (2021-2026)
Table 25. Global Negative Pressure Myofascial Therapy Device Revenue by Application (2021-2026) & ($ million)
Table 26. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Application (2021-2026)
Table 27. Global Negative Pressure Myofascial Therapy Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 28. Global Negative Pressure Myofascial Therapy Device Sales by Company (2021-2026) & (Units)
Table 29. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Company (2021-2026)
Table 30. Global Negative Pressure Myofascial Therapy Device Revenue by Company (2021-2026) & ($ millions)
Table 31. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Company (2021-2026)
Table 32. Global Negative Pressure Myofascial Therapy Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 33. Key Manufacturers Negative Pressure Myofascial Therapy Device Producing Area Distribution and Sales Area
Table 34. Players Negative Pressure Myofascial Therapy Device Products Offered
Table 35. Negative Pressure Myofascial Therapy Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 36. New Products and Potential Entrants
Table 37. Market M&A Activity & Strategy
Table 38. Global Negative Pressure Myofascial Therapy Device Sales by Geographic Region (2021-2026) & (Units)
Table 39. Global Negative Pressure Myofascial Therapy Device Sales Market Share Geographic Region (2021-2026)
Table 40. Global Negative Pressure Myofascial Therapy Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 41. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Geographic Region (2021-2026)
Table 42. Global Negative Pressure Myofascial Therapy Device Sales by Country/Region (2021-2026) & (Units)
Table 43. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Country/Region (2021-2026)
Table 44. Global Negative Pressure Myofascial Therapy Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 45. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Country/Region (2021-2026)
Table 46. Americas Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026) & (Units)
Table 47. Americas Negative Pressure Myofascial Therapy Device Sales Market Share by Country (2021-2026)
Table 48. Americas Negative Pressure Myofascial Therapy Device Revenue by Country (2021-2026) & ($ millions)
Table 49. Americas Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026) & (Units)
Table 50. Americas Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026) & (Units)
Table 51. APAC Negative Pressure Myofascial Therapy Device Sales by Region (2021-2026) & (Units)
Table 52. APAC Negative Pressure Myofascial Therapy Device Sales Market Share by Region (2021-2026)
Table 53. APAC Negative Pressure Myofascial Therapy Device Revenue by Region (2021-2026) & ($ millions)
Table 54. APAC Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026) & (Units)
Table 55. APAC Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026) & (Units)
Table 56. Europe Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026) & (Units)
Table 57. Europe Negative Pressure Myofascial Therapy Device Revenue by Country (2021-2026) & ($ millions)
Table 58. Europe Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026) & (Units)
Table 59. Europe Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026) & (Units)
Table 60. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026) & (Units)
Table 61. Middle East & Africa Negative Pressure Myofascial Therapy Device Revenue Market Share by Country (2021-2026)
Table 62. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026) & (Units)
Table 63. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026) & (Units)
Table 64. Key Market Drivers & Growth Opportunities of Negative Pressure Myofascial Therapy Device
Table 65. Key Market Challenges & Risks of Negative Pressure Myofascial Therapy Device
Table 66. Key Industry Trends of Negative Pressure Myofascial Therapy Device
Table 67. Negative Pressure Myofascial Therapy Device Raw Material
Table 68. Key Suppliers of Raw Materials
Table 69. Negative Pressure Myofascial Therapy Device Distributors List
Table 70. Negative Pressure Myofascial Therapy Device Customer List
Table 71. Global Negative Pressure Myofascial Therapy Device Sales Forecast by Region (2027-2032) & (Units)
Table 72. Global Negative Pressure Myofascial Therapy Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Americas Negative Pressure Myofascial Therapy Device Sales Forecast by Country (2027-2032) & (Units)
Table 74. Americas Negative Pressure Myofascial Therapy Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. APAC Negative Pressure Myofascial Therapy Device Sales Forecast by Region (2027-2032) & (Units)
Table 76. APAC Negative Pressure Myofascial Therapy Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Europe Negative Pressure Myofascial Therapy Device Sales Forecast by Country (2027-2032) & (Units)
Table 78. Europe Negative Pressure Myofascial Therapy Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales Forecast by Country (2027-2032) & (Units)
Table 80. Middle East & Africa Negative Pressure Myofascial Therapy Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Global Negative Pressure Myofascial Therapy Device Sales Forecast by Type (2027-2032) & (Units)
Table 82. Global Negative Pressure Myofascial Therapy Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 83. Global Negative Pressure Myofascial Therapy Device Sales Forecast by Application (2027-2032) & (Units)
Table 84. Global Negative Pressure Myofascial Therapy Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 85. LPG SYSTEMS Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 86. LPG SYSTEMS Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 87. LPG SYSTEMS Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. LPG SYSTEMS Main Business
Table 89. LPG SYSTEMS Latest Developments
Table 90. LymphaTouch Oy Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 91. LymphaTouch Oy Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 92. LymphaTouch Oy Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. LymphaTouch Oy Main Business
Table 94. LymphaTouch Oy Latest Developments
Table 95. pneumed GmbH Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 96. pneumed GmbH Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 97. pneumed GmbH Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. pneumed GmbH Main Business
Table 99. pneumed GmbH Latest Developments
Table 100. ?lectronique du Mazet Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 101. ?lectronique du Mazet Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 102. ?lectronique du Mazet Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. ?lectronique du Mazet Main Business
Table 104. ?lectronique du Mazet Latest Developments
Table 105. EUREDUC Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 106. EUREDUC Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 107. EUREDUC Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. EUREDUC Main Business
Table 109. EUREDUC Latest Developments
Table 110. SKINEXIANS SAS Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 111. SKINEXIANS SAS Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 112. SKINEXIANS SAS Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. SKINEXIANS SAS Main Business
Table 114. SKINEXIANS SAS Latest Developments
Table 115. I-Tech Industries s.r.l. Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 116. I-Tech Industries s.r.l. Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 117. I-Tech Industries s.r.l. Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. I-Tech Industries s.r.l. Main Business
Table 119. I-Tech Industries s.r.l. Latest Developments
Table 120. IBRAMED Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 121. IBRAMED Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 122. IBRAMED Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. IBRAMED Main Business
Table 124. IBRAMED Latest Developments
Table 125. Biotronic Advance Develops Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 126. Biotronic Advance Develops Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 127. Biotronic Advance Develops Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Biotronic Advance Develops Main Business
Table 129. Biotronic Advance Develops Latest Developments
Table 130. 6D Tape Inc. Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 131. 6D Tape Inc. Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 132. 6D Tape Inc. Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. 6D Tape Inc. Main Business
Table 134. 6D Tape Inc. Latest Developments
Table 135. MJ COMPANY Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 136. MJ COMPANY Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 137. MJ COMPANY Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. MJ COMPANY Main Business
Table 139. MJ COMPANY Latest Developments
Table 1. Negative Pressure Myofascial Therapy Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Negative Pressure Myofascial Therapy Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cup Vacuum Mobilization
Table 4. Major Players of Motorized Vacuum Mobilization
Table 5. Major Players of Pneumatic Pulsation Therapy
Table 6. Major Players of Bidirectional Pressure Cycling
Table 7. Major Players of Other
Table 8. Global Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026) & (Units)
Table 9. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
Table 10. Global Negative Pressure Myofascial Therapy Device Revenue by Type (2021-2026) & ($ million)
Table 11. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Type (2021-2026)
Table 12. Global Negative Pressure Myofascial Therapy Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Major Players of Continuous Vacuum
Table 14. Major Players of Pulsed Vacuum
Table 15. Major Players of Intermittent Vacuum
Table 16. Major Players of Bidirectional Pressure
Table 17. Major Players of Other
Table 18. Global Negative Pressure Myofascial Therapy Device Sales by Vacuum Mode (2021-2026) & (Units)
Table 19. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Vacuum Mode (2021-2026)
Table 20. Global Negative Pressure Myofascial Therapy Device Revenue by Vacuum Mode (2021-2026) & ($ million)
Table 21. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Vacuum Mode (2021-2026)
Table 22. Global Negative Pressure Myofascial Therapy Device Sale Price by Vacuum Mode (2021-2026) & (US$/Unit)
Table 23. Global Negative Pressure Myofascial Therapy Device Sale by Application (2021-2026) & (Units)
Table 24. Global Negative Pressure Myofascial Therapy Device Sale Market Share by Application (2021-2026)
Table 25. Global Negative Pressure Myofascial Therapy Device Revenue by Application (2021-2026) & ($ million)
Table 26. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Application (2021-2026)
Table 27. Global Negative Pressure Myofascial Therapy Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 28. Global Negative Pressure Myofascial Therapy Device Sales by Company (2021-2026) & (Units)
Table 29. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Company (2021-2026)
Table 30. Global Negative Pressure Myofascial Therapy Device Revenue by Company (2021-2026) & ($ millions)
Table 31. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Company (2021-2026)
Table 32. Global Negative Pressure Myofascial Therapy Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 33. Key Manufacturers Negative Pressure Myofascial Therapy Device Producing Area Distribution and Sales Area
Table 34. Players Negative Pressure Myofascial Therapy Device Products Offered
Table 35. Negative Pressure Myofascial Therapy Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 36. New Products and Potential Entrants
Table 37. Market M&A Activity & Strategy
Table 38. Global Negative Pressure Myofascial Therapy Device Sales by Geographic Region (2021-2026) & (Units)
Table 39. Global Negative Pressure Myofascial Therapy Device Sales Market Share Geographic Region (2021-2026)
Table 40. Global Negative Pressure Myofascial Therapy Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 41. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Geographic Region (2021-2026)
Table 42. Global Negative Pressure Myofascial Therapy Device Sales by Country/Region (2021-2026) & (Units)
Table 43. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Country/Region (2021-2026)
Table 44. Global Negative Pressure Myofascial Therapy Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 45. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Country/Region (2021-2026)
Table 46. Americas Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026) & (Units)
Table 47. Americas Negative Pressure Myofascial Therapy Device Sales Market Share by Country (2021-2026)
Table 48. Americas Negative Pressure Myofascial Therapy Device Revenue by Country (2021-2026) & ($ millions)
Table 49. Americas Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026) & (Units)
Table 50. Americas Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026) & (Units)
Table 51. APAC Negative Pressure Myofascial Therapy Device Sales by Region (2021-2026) & (Units)
Table 52. APAC Negative Pressure Myofascial Therapy Device Sales Market Share by Region (2021-2026)
Table 53. APAC Negative Pressure Myofascial Therapy Device Revenue by Region (2021-2026) & ($ millions)
Table 54. APAC Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026) & (Units)
Table 55. APAC Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026) & (Units)
Table 56. Europe Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026) & (Units)
Table 57. Europe Negative Pressure Myofascial Therapy Device Revenue by Country (2021-2026) & ($ millions)
Table 58. Europe Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026) & (Units)
Table 59. Europe Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026) & (Units)
Table 60. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Country (2021-2026) & (Units)
Table 61. Middle East & Africa Negative Pressure Myofascial Therapy Device Revenue Market Share by Country (2021-2026)
Table 62. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Type (2021-2026) & (Units)
Table 63. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales by Application (2021-2026) & (Units)
Table 64. Key Market Drivers & Growth Opportunities of Negative Pressure Myofascial Therapy Device
Table 65. Key Market Challenges & Risks of Negative Pressure Myofascial Therapy Device
Table 66. Key Industry Trends of Negative Pressure Myofascial Therapy Device
Table 67. Negative Pressure Myofascial Therapy Device Raw Material
Table 68. Key Suppliers of Raw Materials
Table 69. Negative Pressure Myofascial Therapy Device Distributors List
Table 70. Negative Pressure Myofascial Therapy Device Customer List
Table 71. Global Negative Pressure Myofascial Therapy Device Sales Forecast by Region (2027-2032) & (Units)
Table 72. Global Negative Pressure Myofascial Therapy Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 73. Americas Negative Pressure Myofascial Therapy Device Sales Forecast by Country (2027-2032) & (Units)
Table 74. Americas Negative Pressure Myofascial Therapy Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 75. APAC Negative Pressure Myofascial Therapy Device Sales Forecast by Region (2027-2032) & (Units)
Table 76. APAC Negative Pressure Myofascial Therapy Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Europe Negative Pressure Myofascial Therapy Device Sales Forecast by Country (2027-2032) & (Units)
Table 78. Europe Negative Pressure Myofascial Therapy Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales Forecast by Country (2027-2032) & (Units)
Table 80. Middle East & Africa Negative Pressure Myofascial Therapy Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Global Negative Pressure Myofascial Therapy Device Sales Forecast by Type (2027-2032) & (Units)
Table 82. Global Negative Pressure Myofascial Therapy Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 83. Global Negative Pressure Myofascial Therapy Device Sales Forecast by Application (2027-2032) & (Units)
Table 84. Global Negative Pressure Myofascial Therapy Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 85. LPG SYSTEMS Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 86. LPG SYSTEMS Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 87. LPG SYSTEMS Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. LPG SYSTEMS Main Business
Table 89. LPG SYSTEMS Latest Developments
Table 90. LymphaTouch Oy Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 91. LymphaTouch Oy Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 92. LymphaTouch Oy Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. LymphaTouch Oy Main Business
Table 94. LymphaTouch Oy Latest Developments
Table 95. pneumed GmbH Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 96. pneumed GmbH Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 97. pneumed GmbH Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. pneumed GmbH Main Business
Table 99. pneumed GmbH Latest Developments
Table 100. ?lectronique du Mazet Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 101. ?lectronique du Mazet Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 102. ?lectronique du Mazet Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. ?lectronique du Mazet Main Business
Table 104. ?lectronique du Mazet Latest Developments
Table 105. EUREDUC Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 106. EUREDUC Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 107. EUREDUC Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. EUREDUC Main Business
Table 109. EUREDUC Latest Developments
Table 110. SKINEXIANS SAS Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 111. SKINEXIANS SAS Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 112. SKINEXIANS SAS Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. SKINEXIANS SAS Main Business
Table 114. SKINEXIANS SAS Latest Developments
Table 115. I-Tech Industries s.r.l. Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 116. I-Tech Industries s.r.l. Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 117. I-Tech Industries s.r.l. Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. I-Tech Industries s.r.l. Main Business
Table 119. I-Tech Industries s.r.l. Latest Developments
Table 120. IBRAMED Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 121. IBRAMED Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 122. IBRAMED Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. IBRAMED Main Business
Table 124. IBRAMED Latest Developments
Table 125. Biotronic Advance Develops Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 126. Biotronic Advance Develops Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 127. Biotronic Advance Develops Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Biotronic Advance Develops Main Business
Table 129. Biotronic Advance Develops Latest Developments
Table 130. 6D Tape Inc. Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 131. 6D Tape Inc. Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 132. 6D Tape Inc. Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. 6D Tape Inc. Main Business
Table 134. 6D Tape Inc. Latest Developments
Table 135. MJ COMPANY Basic Information, Negative Pressure Myofascial Therapy Device Manufacturing Base, Sales Area and Its Competitors
Table 136. MJ COMPANY Negative Pressure Myofascial Therapy Device Product Portfolios and Specifications
Table 137. MJ COMPANY Negative Pressure Myofascial Therapy Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. MJ COMPANY Main Business
Table 139. MJ COMPANY Latest Developments
LIST OF FIGURES
Figure 1. Picture of Negative Pressure Myofascial Therapy Device
Figure 2. Negative Pressure Myofascial Therapy Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Negative Pressure Myofascial Therapy Device Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Negative Pressure Myofascial Therapy Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Negative Pressure Myofascial Therapy Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Negative Pressure Myofascial Therapy Device Sales Market Share by Country/Region (2025)
Figure 10. Negative Pressure Myofascial Therapy Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cup Vacuum Mobilization
Figure 12. Product Picture of Motorized Vacuum Mobilization
Figure 13. Product Picture of Pneumatic Pulsation Therapy
Figure 14. Product Picture of Bidirectional Pressure Cycling
Figure 15. Product Picture of Other
Figure 16. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Type in 2026
Figure 17. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Continuous Vacuum
Figure 19. Product Picture of Pulsed Vacuum
Figure 20. Product Picture of Intermittent Vacuum
Figure 21. Product Picture of Bidirectional Pressure
Figure 22. Product Picture of Other
Figure 23. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Vacuum Mode in 2026
Figure 24. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Vacuum Mode (2021-2026)
Figure 25. Negative Pressure Myofascial Therapy Device Consumed in Myofascial Rehabilitation
Figure 26. Global Negative Pressure Myofascial Therapy Device Market: Myofascial Rehabilitation (2021-2026) & (Units)
Figure 27. Negative Pressure Myofascial Therapy Device Consumed in Scar Rehabilitation
Figure 28. Global Negative Pressure Myofascial Therapy Device Market: Scar Rehabilitation (2021-2026) & (Units)
Figure 29. Negative Pressure Myofascial Therapy Device Consumed in Edema Management
Figure 30. Global Negative Pressure Myofascial Therapy Device Market: Edema Management (2021-2026) & (Units)
Figure 31. Negative Pressure Myofascial Therapy Device Consumed in Sports Recovery
Figure 32. Global Negative Pressure Myofascial Therapy Device Market: Sports Recovery (2021-2026) & (Units)
Figure 33. Negative Pressure Myofascial Therapy Device Consumed in Other
Figure 34. Global Negative Pressure Myofascial Therapy Device Market: Other (2021-2026) & (Units)
Figure 35. Global Negative Pressure Myofascial Therapy Device Sale Market Share by Application (2025)
Figure 36. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Application in 2025
Figure 37. Negative Pressure Myofascial Therapy Device Sales by Company in 2025 (Units)
Figure 38. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Company in 2025
Figure 39. Negative Pressure Myofascial Therapy Device Revenue by Company in 2025 ($ millions)
Figure 40. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Company in 2025
Figure 41. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Negative Pressure Myofascial Therapy Device Sales 2021-2026 (Units)
Figure 44. Americas Negative Pressure Myofascial Therapy Device Revenue 2021-2026 ($ millions)
Figure 45. APAC Negative Pressure Myofascial Therapy Device Sales 2021-2026 (Units)
Figure 46. APAC Negative Pressure Myofascial Therapy Device Revenue 2021-2026 ($ millions)
Figure 47. Europe Negative Pressure Myofascial Therapy Device Sales 2021-2026 (Units)
Figure 48. Europe Negative Pressure Myofascial Therapy Device Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales 2021-2026 (Units)
Figure 50. Middle East & Africa Negative Pressure Myofascial Therapy Device Revenue 2021-2026 ($ millions)
Figure 51. Americas Negative Pressure Myofascial Therapy Device Sales Market Share by Country in 2025
Figure 52. Americas Negative Pressure Myofascial Therapy Device Revenue Market Share by Country (2021-2026)
Figure 53. Americas Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
Figure 54. Americas Negative Pressure Myofascial Therapy Device Sales Market Share by Application (2021-2026)
Figure 55. United States Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Negative Pressure Myofascial Therapy Device Sales Market Share by Region in 2025
Figure 60. APAC Negative Pressure Myofascial Therapy Device Revenue Market Share by Region (2021-2026)
Figure 61. APAC Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
Figure 62. APAC Negative Pressure Myofascial Therapy Device Sales Market Share by Application (2021-2026)
Figure 63. China Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 67. India Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Negative Pressure Myofascial Therapy Device Sales Market Share by Country in 2025
Figure 71. Europe Negative Pressure Myofascial Therapy Device Revenue Market Share by Country (2021-2026)
Figure 72. Europe Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
Figure 73. Europe Negative Pressure Myofascial Therapy Device Sales Market Share by Application (2021-2026)
Figure 74. Germany Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 75. France Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales Market Share by Application (2021-2026)
Figure 82. Egypt Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Negative Pressure Myofascial Therapy Device in 2026
Figure 88. Manufacturing Process Analysis of Negative Pressure Myofascial Therapy Device
Figure 89. Industry Chain Structure of Negative Pressure Myofascial Therapy Device
Figure 90. Channels of Distribution
Figure 91. Global Negative Pressure Myofascial Therapy Device Sales Market Forecast by Region (2027-2032)
Figure 92. Global Negative Pressure Myofascial Therapy Device Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Negative Pressure Myofascial Therapy Device Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Negative Pressure Myofascial Therapy Device Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Negative Pressure Myofascial Therapy Device Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Negative Pressure Myofascial Therapy Device Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Negative Pressure Myofascial Therapy Device
Figure 2. Negative Pressure Myofascial Therapy Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Negative Pressure Myofascial Therapy Device Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Negative Pressure Myofascial Therapy Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Negative Pressure Myofascial Therapy Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Negative Pressure Myofascial Therapy Device Sales Market Share by Country/Region (2025)
Figure 10. Negative Pressure Myofascial Therapy Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cup Vacuum Mobilization
Figure 12. Product Picture of Motorized Vacuum Mobilization
Figure 13. Product Picture of Pneumatic Pulsation Therapy
Figure 14. Product Picture of Bidirectional Pressure Cycling
Figure 15. Product Picture of Other
Figure 16. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Type in 2026
Figure 17. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of Continuous Vacuum
Figure 19. Product Picture of Pulsed Vacuum
Figure 20. Product Picture of Intermittent Vacuum
Figure 21. Product Picture of Bidirectional Pressure
Figure 22. Product Picture of Other
Figure 23. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Vacuum Mode in 2026
Figure 24. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Vacuum Mode (2021-2026)
Figure 25. Negative Pressure Myofascial Therapy Device Consumed in Myofascial Rehabilitation
Figure 26. Global Negative Pressure Myofascial Therapy Device Market: Myofascial Rehabilitation (2021-2026) & (Units)
Figure 27. Negative Pressure Myofascial Therapy Device Consumed in Scar Rehabilitation
Figure 28. Global Negative Pressure Myofascial Therapy Device Market: Scar Rehabilitation (2021-2026) & (Units)
Figure 29. Negative Pressure Myofascial Therapy Device Consumed in Edema Management
Figure 30. Global Negative Pressure Myofascial Therapy Device Market: Edema Management (2021-2026) & (Units)
Figure 31. Negative Pressure Myofascial Therapy Device Consumed in Sports Recovery
Figure 32. Global Negative Pressure Myofascial Therapy Device Market: Sports Recovery (2021-2026) & (Units)
Figure 33. Negative Pressure Myofascial Therapy Device Consumed in Other
Figure 34. Global Negative Pressure Myofascial Therapy Device Market: Other (2021-2026) & (Units)
Figure 35. Global Negative Pressure Myofascial Therapy Device Sale Market Share by Application (2025)
Figure 36. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Application in 2025
Figure 37. Negative Pressure Myofascial Therapy Device Sales by Company in 2025 (Units)
Figure 38. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Company in 2025
Figure 39. Negative Pressure Myofascial Therapy Device Revenue by Company in 2025 ($ millions)
Figure 40. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Company in 2025
Figure 41. Global Negative Pressure Myofascial Therapy Device Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Negative Pressure Myofascial Therapy Device Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Negative Pressure Myofascial Therapy Device Sales 2021-2026 (Units)
Figure 44. Americas Negative Pressure Myofascial Therapy Device Revenue 2021-2026 ($ millions)
Figure 45. APAC Negative Pressure Myofascial Therapy Device Sales 2021-2026 (Units)
Figure 46. APAC Negative Pressure Myofascial Therapy Device Revenue 2021-2026 ($ millions)
Figure 47. Europe Negative Pressure Myofascial Therapy Device Sales 2021-2026 (Units)
Figure 48. Europe Negative Pressure Myofascial Therapy Device Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales 2021-2026 (Units)
Figure 50. Middle East & Africa Negative Pressure Myofascial Therapy Device Revenue 2021-2026 ($ millions)
Figure 51. Americas Negative Pressure Myofascial Therapy Device Sales Market Share by Country in 2025
Figure 52. Americas Negative Pressure Myofascial Therapy Device Revenue Market Share by Country (2021-2026)
Figure 53. Americas Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
Figure 54. Americas Negative Pressure Myofascial Therapy Device Sales Market Share by Application (2021-2026)
Figure 55. United States Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Negative Pressure Myofascial Therapy Device Sales Market Share by Region in 2025
Figure 60. APAC Negative Pressure Myofascial Therapy Device Revenue Market Share by Region (2021-2026)
Figure 61. APAC Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
Figure 62. APAC Negative Pressure Myofascial Therapy Device Sales Market Share by Application (2021-2026)
Figure 63. China Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 67. India Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Negative Pressure Myofascial Therapy Device Sales Market Share by Country in 2025
Figure 71. Europe Negative Pressure Myofascial Therapy Device Revenue Market Share by Country (2021-2026)
Figure 72. Europe Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
Figure 73. Europe Negative Pressure Myofascial Therapy Device Sales Market Share by Application (2021-2026)
Figure 74. Germany Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 75. France Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Negative Pressure Myofascial Therapy Device Sales Market Share by Application (2021-2026)
Figure 82. Egypt Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Negative Pressure Myofascial Therapy Device Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Negative Pressure Myofascial Therapy Device in 2026
Figure 88. Manufacturing Process Analysis of Negative Pressure Myofascial Therapy Device
Figure 89. Industry Chain Structure of Negative Pressure Myofascial Therapy Device
Figure 90. Channels of Distribution
Figure 91. Global Negative Pressure Myofascial Therapy Device Sales Market Forecast by Region (2027-2032)
Figure 92. Global Negative Pressure Myofascial Therapy Device Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Negative Pressure Myofascial Therapy Device Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Negative Pressure Myofascial Therapy Device Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Negative Pressure Myofascial Therapy Device Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Negative Pressure Myofascial Therapy Device Revenue Market Share Forecast by Application (2027-2032)
